Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$137,450 | -$228,491 | $275,506 | -$153,285 |
| Dep. & Amort. | $0 | $6,970 | $6,730 | $9,233 |
| Deferred Tax | $0 | -$36 | $36 | -$2,270 |
| Stock-Based Comp. | $0 | $24,109 | $24,975 | $25,855 |
| Change in WC | -$846,541 | $729,626 | $587,543 | $473,838 |
| Other Non-Cash | $19,333 | -$23,111 | -$16,248 | -$6,551 |
| Operating Cash Flow | -$964,658 | $509,067 | $878,542 | $346,820 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,007 | -$9,277 | -$9,026 | -$6,819 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$172,835 | -$270,969 | -$336,869 | -$110,461 |
| Inv. Sales/Matur. | $332,449 | $111,513 | $171,667 | $85,845 |
| Other Inv. Act. | -$526 | $526 | $0 | -$13 |
| Investing Cash Flow | $150,081 | -$168,207 | -$174,228 | -$31,448 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $352,883 | $0 | $0 | $0 |
| Stock Issued | $12,897 | $23,567 | $5,728 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,746 | -$1,434 | -$855 | $3,817 |
| Financing Cash Flow | $364,034 | $22,133 | $4,873 | $3,817 |
| Forex Effect | $466 | $0 | $0 | $0 |
| Net Chg. in Cash | -$450,077 | $362,993 | $709,187 | $319,189 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,598,942 | $2,260,305 | $1,551,118 | $1,231,929 |
| End Cash | $2,148,865 | $2,623,298 | $2,260,305 | $1,551,118 |
| Free Cash Flow | -$973,665 | $499,790 | $869,516 | $340,001 |